Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2003
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474943A1 Sugar stabilized antibody-containing solution formulations
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2474670A1 Diagnostic method for stroke
08/21/2003CA2474405A1 Medicament for the treatment of choroidal neovascularisation
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336654A1 Method of treating psoriasis using anti-gamma interferon antibody
08/20/2003EP1336621A2 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/20/2003EP1336617A2 Conotoxins having acetylcholin receptor binding properties
08/20/2003EP1336616A1 Activated peptides and conjugates
08/20/2003EP1336410A1 Protein injection preparations
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335972A2 Tolerizing allografts of pluripotent stem cells
08/20/2003EP1335953A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
08/20/2003EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
08/20/2003EP1335926A2 Method of separating extra-chromosomal dna from other cellular components
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1335744A2 Sdf-1 beta expressing tumor cells as tumor vaccines
08/20/2003EP1335743A1 Inhibition or reversal of skin aging by actin-sequestering peptides
08/20/2003EP1335742A1 Atherosclerosis vaccine
08/20/2003EP1335741A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1093381B1 Antigenic peptides derived from telomerase
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003EP0693938B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437613A Modified morbillivirus V proteins
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437482A Recombinant or purified polyclonal antibodies for treating allergy
08/20/2003CN1437481A QS-21 and IL-12 as an adjuvant combination
08/20/2003CN1437480A Compositions and methods for treatment of mucosal infections
08/20/2003CN1437479A Recombinant intracellular pathogen vaccines and methods for use
08/20/2003CN1437478A Intrathecal administration of Rituximab for treatment of central nervous system lymphomas
08/20/2003CN1437476A Optimized minigenes and peptides encoded thereby
08/20/2003CN1436790A Fowl castration vaccine gene and recombinant gene vector
08/20/2003CN1436788A Universal farm animal castration vaccine gene and recombinant gene vector
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118474C Synthetic peptides and vaccines containing the same
08/20/2003CN1118299C Gonococcal anti-idiotypic antibodies and using methods and composition thereof
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608179 Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607753 Converting extract of Tribulus furostanol saponin compounds to spirostanol compounds; hydrolysis, separation; topical application
08/19/2003US6607732 ISCOM or ISCOM-matrix comprising a mucous targetting substance and an antigen
08/19/2003US6607731 Fusion protein; vaccines
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607729 Surface antigen
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607727 Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
08/19/2003US6607725 Conjugate vaccine for nontypeable Haemophilus influenzae
08/19/2003US6607723 Removing preformed antibodies to various identified carbohydrate xenoantigens from recipient's circulation prior to transplantation by extracorporeal perfusion
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003CA2165953C Prostaglandin receptor ep3 and dna encoding it
08/19/2003CA2138258C Synthetic peptides for the treatment of myasthenia gravis
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/19/2003CA2112225C Attenuated revertant serotype 1 marek's disease vaccine
08/19/2003CA2095854C Mycobacterium vaccae in the treatment of uveitis
08/19/2003CA2059693C Polysaccharide antigens from streptococcus pneumoniae
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/15/2003WO2004087941A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/15/2003CA2475206A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066880A2 Method for accessing microbial diversity
08/14/2003WO2003066877A2 Compositions and methods relating to hepatic specific genes and proteins
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066833A2 Use of recombinant hepatitis b core particles to develop vaccines against infectious pathogens and malignancies
08/14/2003WO2003066830A2 Human monoclonal antibodies against membrane proteins
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066807A2 Method of inhibiting pathogenicity of infectious agents
08/14/2003WO2003066680A2 Antigens for immunocontraception
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066096A1 Polymeric conjugates for delivery of mhc-recognized epitopes via peptide vaccines
08/14/2003WO2003066095A2 MODULATING TOLERANCE BY MODULATING FcϜRIIB RECEPTOR SIGNALLING
08/14/2003WO2003066094A2 Hepatitis b vaccines
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066092A1 A method of producing and using heat shock proteins
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003066078A1 Hiv inhibiting proteins
1 ... 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 ... 1823